Baker Avenue Asset Management, LP Novo Nordisk A S Transaction History

Baker Avenue Asset Management, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$102.11 - $135.92 $173,587 - $231,063	1,700 New	1,700 $218,000
Q3 2023 Nov 14, 2023	BUY	$90.94 - $199.54 $33,556 - $73,630	369 Added 100.0%	738 $67,000
Q2 2023 Aug 11, 2023	SELL	$155.98 - $172.65 $6,395 - $7,078	-41 Reduced 10.0%	369 $59,000
Q1 2023 May 15, 2023	BUY	$132.34 - $159.14 $5,425 - $6,524	41 Added 11.11%	410 $65,000
Q4 2022 Feb 13, 2023	BUY	$102.55 - $135.33 $37,840 - $49,936	369 New	369 $49,000

1,955

320M

5.49M

7.78M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $246B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Baker Avenue Asset Management, LP, based on Form 13F filings with the SEC.

Stay updated on Baker Avenue Asset Management, LP with notifications on news.